Takip et
Mesut Sancar
Mesut Sancar
marmara.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children
EC Dinleyici, PROBAGE Study Group, Y Vandenplas, N Dalgic, S Guven, ...
Acta Paediatrica 103 (7), e300-e305, 2014
1052014
Assessment of medication knowledge and adherence among patients under oral chronic medication treatment in community pharmacy settings
B Okuyan, M Sancar, FV Izzettin
Pharmacoepidemiology and drug safety 22 (2), 209-214, 2013
972013
Effect of a pharmacist-led program on improving outcomes in patients with type 2 diabetes mellitus from Northern Cyprus: a randomized controlled trial
EI Korcegez, M Sancar, K Demirkan
Journal of managed care & specialty pharmacy 23 (5), 573-582, 2017
932017
Arg753Gln polymorphism of the human Toll-like receptor 2 gene from infection to disease in pediatric tuberculosis
N Dalgic, D Tekin, Z Kayaalti, T Soylemezoglu, E Cakir, B Kilic, B Kutlubay, ...
Human immunology 72 (5), 440-445, 2011
892011
Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting
EC Dinleyici, N Dalgic, S Guven, O Metin, O Yasa, Z Kurugol, O Turel, ...
Jornal de pediatria 91, 392-396, 2015
822015
Probiotic, zinc and lactose‐free formula in children with rotavirus diarrhea: are they effective?
N Dalgic, M Sancar, B Bayraktar, M Pullu, O Hasim
Pediatrics International 53 (5), 677-682, 2011
812011
Protective effect of ferulic acid on cisplatin induced nephrotoxicity in rats
E Bami, OB Ozakpınar, ZN Ozdemir-Kumral, K Köroglu, F Ercan, Z Cirakli, ...
Environmental toxicology and pharmacology 54, 105-111, 2017
792017
Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey
N Abunahlah, A Elawaisi, FM Velibeyoglu, M Sancar
International journal of clinical pharmacy 40 (2), 360-367, 2018
772018
Relationship between toll-like receptor 8 gene polymorphisms and pediatric pulmonary tuberculosis
N Dalgic, D Tekin, Z Kayaalti, E Cakir, T Soylemezoglu, M Sancar
Disease markers 31 (1), 33-38, 2011
752011
The effect of a multispecies synbiotic mixture on the duration of diarrhea and length of hospital stay in children with acute diarrhea in Turkey: single blinded randomized study
EC Dinleyici, N Dalgic, S Guven, M Ozen, A Kara, V Arica, O Metin-Timur, ...
European Journal of Pediatrics 172, 459-464, 2013
712013
Successful treatment of multidrug-resistant Acinetobacter baumanii ventriculitis with intravenous and intraventricular colistin
N Dalgic, Y Ceylan, M Sancar, L Telhan, I Kafadar, H Cavusoglu, ...
Annals of tropical paediatrics 29 (2), 141-147, 2009
562009
COVID-19 vaccination scenarios: a cost-effectiveness analysis for Turkey
A Hagens, AÇ İnkaya, K Yildirak, M Sancar, J Van Der Schans, ...
Vaccines 9 (4), 399, 2021
502021
Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children
N Dalgic, M Sancar, B Bayraktar, E Dincer, S Pelit
Scandinavian journal of infectious diseases 43 (5), 339-343, 2011
502011
Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea
EC Dinleyici, A Kara, N Dalgic, Z Kurugol, V Arica, O Metin, E Temur, ...
Beneficial Microbes 6 (4), 415-421, 2015
492015
Opinion and knowledge towards pharmaceutical care of the pharmacists participated in clinical pharmacy and pharmaceutical care continuing education program
M Sancar, B Okuyan, S Apikoglu-Rabus, F Izzettin
Turk J Pharm Sci 10 (2), 245-254, 2013
402013
Linezolid treatment of shunt-related cerebrospinal fluid infections in children
A Yılmaz, N Dalgic, M Müslüman, M Sancar, I Çolak, Y Aydın
Journal of Neurosurgery: Pediatrics 5 (5), 443-448, 2010
382010
Improvement of diabetes indices of care by a short pharmaceutical care program
M Turnacilar, M Sancar, S Apikoglu-Rabus, M Hursitoglu, FV Izzettin
Pharmacy world & science 31, 689-695, 2009
372009
Is rotavirus diarrhea a systemic viral infection?
N Dalgıç, Ö Haşim, M Pullu, M Sancar, İ Kafadar, A Yılmaz
Journal of Pediatric Infection/Cocuk Enfeksiyon Dergisi 4 (2), 2010
362010
Therapeutic monitoring of isoniazid, pyrazinamide and rifampicin in tuberculosis patients using LC
S Unsalan, M Sancar, B Bekce, PM Clark, T Karagoz, FV Izzettin, S Rollas
Chromatographia 61, 595-598, 2005
352005
Adverse drug reactions due to drug–drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR method
E Yucel, M Sancar, A Yucel, B Okuyan
Expert opinion on drug safety 15 (2), 223-236, 2016
332016
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20